Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/16/2013 05/17/2013 05/20/2013 05/21/2013 05/22/2013 Date
10.6(c) 11.27(c) 10.7(c) 10.85(c) 10.98 Last
78 451 175 051 124 758 75 195 143 880 Volume
+0.66% +6.32% -5.06% +1.40% +1.20% Change
More quotes
Company
Sector
Biotechnology
Calendar
08/08Earnings Release
Surperformance© rating of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More about the company
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 20,2 M
EBIT 2013 -10,2 M
Net income 2013 -10,2 M
Debt 2013 -
Yield 2013 -
Sales 2014 32,5 M
EBIT 2014 -5,01 M
Net income 2014 -4,99 M
Debt 2014 -
Yield 2014 -
PER 2013 -
PER 2014
Capi. / Sales 2013 17,6x
Capi. / Sales 2014 11,0x
Capitalization 357 M
More Financials
Latest news on OSIRIS THERAPEUTICS, INC.
05/07 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Announces First Quarter 2013 Fin..
04/29 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics to Present at the 12th Annual Ne..
04/25 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Announces First Quarter 2013 Fin..
03/14 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics to Present at the Canaccord Genu..
03/01 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Establishes Direct Sales Force f..
02/22 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Announces Fourth Quarter and Ful..
02/19 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Receives Title of European Orpha..
02/18 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Successfully Defends Key Stem Ce..
2012 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics to Present at the 24th Annual Pi..
2012 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Reports Third Quarter 2012 Finan..
2012 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Announces Third Quarter 2012 Fin..
2012 OSIRIS THERAPEUTICS, INC.: Osiris Therapeutics Names Lode Debrabandere Chief Op..
More news
Forum OSIRIS THERAPEUTICS, INC.
Be the first to post a message on OSIRIS THERAPEUTICS, INC.
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
Osiris Therapeutics, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Osiris Therapeutics, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.